
UGA Biopharma
Hennigsdorf, Germany ugabiopharma.com From their website, Nov 2026
- ISO 9001
Work here? Claim this listing
About
UGA Biopharma develops cell lines, upstream and downstream processes, and analytical methods for biologics and biosimilars. It also offers ready-to-use CHO-based cell lines and proprietary CHO Prime media and feed products. The company is based in Hennigsdorf near Berlin, Germany, and works with customers in biopharmaceutical development.
Services
Cell Line Development (CLD)
Develops stable, high-performance cell lines using proprietary expression vectors, adapted CHO host cells, cloning, screening, stability studies, and cell bank generation.
Cell line development
Upstream Processing (USP)
Develops and optimizes scalable upstream bioprocesses, from small-scale clone screening in Ambr 15 bioreactors to cultivation in 5-litre bioreactors.
Cell line development
Downstream Processing (DSP)
Develops customized, scalable protein purification processes using chromatographic methods and product-quality monitoring throughout purification.
Cell line development
Analytical Development
Develops analytical procedures to monitor critical quality attributes and characterize bioprocess performance and product quality.
Ready-to-Use cell lines (R2U-Cells)
Provides ready-to-use CHO-based cell lines for biosimilar expression, including lines for recombinant enzymes referenced on the site.
Cell line development
CHO Prime media and feeds
Provides proprietary CHO Prime media and matched feed products for cell culture and fed-batch cultivation.
Analytical Method Development
Develops analysis methods to determine productivity and critical quality attributes.
Ready-to-Use (R2U) cell lines
Provides ready-to-use CHO cell lines for biosimilars, including cell lines expressing specific recombinant enzymes.
Cell line development
1 more services
- CHO Prime® Media & Feeds
- What to send
- Gene synthesis and cloning into proprietary expression vectors
- Detailed documentation in line with regulatory requirements
Capabilities
- Assays and studies
- CHO
- Analytical development
- Charge variant analysis
- N-glycan analysis
- Ion exchange chromatography
- HILIC chromatography
10 more
- Hydrophobic interaction chromatography
- Size exclusion chromatography
- Peptide mapping
- SDS-PAGE
- Western blotting
- ELISA
- In-vitro activity testing
- LC-MS
- Analytical method development
- Critical quality attribute (CQA) monitoring
- Scale and capacity
- Parallel experiments on a small scale
- 5-litre bioreactors
- 96-well filter plates
- Column format
- Therapeutic areas
- Rare diseases
- Pompe disease
- Mucopolysaccharidosis type VI
Instruments and platforms
- Ambr 15 bioreactors
- FPLC (ÄKTA)
- UF/DF systems
Modalities and species
- Modalities
- Antibody
- Peptide
- Recombinant protein
- Biosimilar
- Species and models
- CHO cells
- CHO-DG44
- CHO-K1
- CHO-DXB11
- CHO
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 9001Self-reported
Industries served
- Biologics
- Biosimilars
- Biopharmaceuticals
Details
- Type
- CRO
- Founded
- 2009
- Address
- Neuendorfstraße 20a 16761 Hennigsdorf (bei Berlin)
- Serves
- International, worldwide
- Phone
- +49 3302 / 20 24 900